Cargando…

Ethyl P-Methoxycinnamate: An Active Anti-Metastasis Agent and Chemosensitizer Targeting NFκB from Kaempferia galanga for Melanoma Cells

The most common type of skin cancer is melanoma. While significant advances in chemotherapy have occurred in a few instances, only marginal progress has been made in treating metastatic melanoma. Natural medicine has traditionally been used to treat various illnesses, including cancer. The purpose o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lallo, Subehan, Hardianti, Besse, Sartini, Sartini, Ismail, Ismail, Laela, Dewi, Hayakawa, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950268/
https://www.ncbi.nlm.nih.gov/pubmed/35330088
http://dx.doi.org/10.3390/life12030337
_version_ 1784675100422832128
author Lallo, Subehan
Hardianti, Besse
Sartini, Sartini
Ismail, Ismail
Laela, Dewi
Hayakawa, Yoshihiro
author_facet Lallo, Subehan
Hardianti, Besse
Sartini, Sartini
Ismail, Ismail
Laela, Dewi
Hayakawa, Yoshihiro
author_sort Lallo, Subehan
collection PubMed
description The most common type of skin cancer is melanoma. While significant advances in chemotherapy have occurred in a few instances, only marginal progress has been made in treating metastatic melanoma. Natural medicine has traditionally been used to treat various illnesses, including cancer. The purpose of this study was to identify the active compound in Kaempferia galanga, which could be used to treat melanoma as an anti-metastasis and chemosensitizer agent. The active compound in K. galanga was isolated and identified using chromatography and spectroscopy techniques, and given six compounds. Inhibitory activity on NFκB activation and cell viability was determined using reporter assay methods. Among the isolated compounds, ethyl p-methoxycinnamate (EPMC) demonstrated potent NFκB inhibitory activity against melanoma cell B16F10- NFκB Luc2 with an IC50 of 88.7 μM. Further investigation was conducted by evaluating the anti-metastasis effect of EPMC in vitro by using wound-healing assays, invasion tests, and molecular mechanism assays using Western blotting. NFκB has been implicated in tumorigenesis through the PI3K/Akt/NFκB pathway. The results of this study indicated that EPMCs act as inhibitors of p38 and thereby Akt phosphorylation inhibitors at serine 473, inhibiting NFκB-dependent transcription. Further analysis with paclitaxel demonstrated that the combinations could sensitize to apoptosis in response to well-known chemotherapy agents. Additional studies were conducted using the human melanoma cancer cell line SK-Mel 28. Along with the induction of apoptosis, we observed an increase in p-γH2AX expression (a molecular marker for double strand breaks in DNA damage) in response to treatment with paclitaxel and EPMC. The result showed EPMC to be a potential, viable adjuvant for improving the clinical efficacy of anti-metastatic and cancer chemotherapy.
format Online
Article
Text
id pubmed-8950268
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89502682022-03-26 Ethyl P-Methoxycinnamate: An Active Anti-Metastasis Agent and Chemosensitizer Targeting NFκB from Kaempferia galanga for Melanoma Cells Lallo, Subehan Hardianti, Besse Sartini, Sartini Ismail, Ismail Laela, Dewi Hayakawa, Yoshihiro Life (Basel) Article The most common type of skin cancer is melanoma. While significant advances in chemotherapy have occurred in a few instances, only marginal progress has been made in treating metastatic melanoma. Natural medicine has traditionally been used to treat various illnesses, including cancer. The purpose of this study was to identify the active compound in Kaempferia galanga, which could be used to treat melanoma as an anti-metastasis and chemosensitizer agent. The active compound in K. galanga was isolated and identified using chromatography and spectroscopy techniques, and given six compounds. Inhibitory activity on NFκB activation and cell viability was determined using reporter assay methods. Among the isolated compounds, ethyl p-methoxycinnamate (EPMC) demonstrated potent NFκB inhibitory activity against melanoma cell B16F10- NFκB Luc2 with an IC50 of 88.7 μM. Further investigation was conducted by evaluating the anti-metastasis effect of EPMC in vitro by using wound-healing assays, invasion tests, and molecular mechanism assays using Western blotting. NFκB has been implicated in tumorigenesis through the PI3K/Akt/NFκB pathway. The results of this study indicated that EPMCs act as inhibitors of p38 and thereby Akt phosphorylation inhibitors at serine 473, inhibiting NFκB-dependent transcription. Further analysis with paclitaxel demonstrated that the combinations could sensitize to apoptosis in response to well-known chemotherapy agents. Additional studies were conducted using the human melanoma cancer cell line SK-Mel 28. Along with the induction of apoptosis, we observed an increase in p-γH2AX expression (a molecular marker for double strand breaks in DNA damage) in response to treatment with paclitaxel and EPMC. The result showed EPMC to be a potential, viable adjuvant for improving the clinical efficacy of anti-metastatic and cancer chemotherapy. MDPI 2022-02-24 /pmc/articles/PMC8950268/ /pubmed/35330088 http://dx.doi.org/10.3390/life12030337 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lallo, Subehan
Hardianti, Besse
Sartini, Sartini
Ismail, Ismail
Laela, Dewi
Hayakawa, Yoshihiro
Ethyl P-Methoxycinnamate: An Active Anti-Metastasis Agent and Chemosensitizer Targeting NFκB from Kaempferia galanga for Melanoma Cells
title Ethyl P-Methoxycinnamate: An Active Anti-Metastasis Agent and Chemosensitizer Targeting NFκB from Kaempferia galanga for Melanoma Cells
title_full Ethyl P-Methoxycinnamate: An Active Anti-Metastasis Agent and Chemosensitizer Targeting NFκB from Kaempferia galanga for Melanoma Cells
title_fullStr Ethyl P-Methoxycinnamate: An Active Anti-Metastasis Agent and Chemosensitizer Targeting NFκB from Kaempferia galanga for Melanoma Cells
title_full_unstemmed Ethyl P-Methoxycinnamate: An Active Anti-Metastasis Agent and Chemosensitizer Targeting NFκB from Kaempferia galanga for Melanoma Cells
title_short Ethyl P-Methoxycinnamate: An Active Anti-Metastasis Agent and Chemosensitizer Targeting NFκB from Kaempferia galanga for Melanoma Cells
title_sort ethyl p-methoxycinnamate: an active anti-metastasis agent and chemosensitizer targeting nfκb from kaempferia galanga for melanoma cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950268/
https://www.ncbi.nlm.nih.gov/pubmed/35330088
http://dx.doi.org/10.3390/life12030337
work_keys_str_mv AT lallosubehan ethylpmethoxycinnamateanactiveantimetastasisagentandchemosensitizertargetingnfkbfromkaempferiagalangaformelanomacells
AT hardiantibesse ethylpmethoxycinnamateanactiveantimetastasisagentandchemosensitizertargetingnfkbfromkaempferiagalangaformelanomacells
AT sartinisartini ethylpmethoxycinnamateanactiveantimetastasisagentandchemosensitizertargetingnfkbfromkaempferiagalangaformelanomacells
AT ismailismail ethylpmethoxycinnamateanactiveantimetastasisagentandchemosensitizertargetingnfkbfromkaempferiagalangaformelanomacells
AT laeladewi ethylpmethoxycinnamateanactiveantimetastasisagentandchemosensitizertargetingnfkbfromkaempferiagalangaformelanomacells
AT hayakawayoshihiro ethylpmethoxycinnamateanactiveantimetastasisagentandchemosensitizertargetingnfkbfromkaempferiagalangaformelanomacells